EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Biophysical and structural analysis of KRAS switch-II pocket inhibitors reveals allele-specific binding constraints

Patrick Alexander, Albert H Chan, Dana Rabara, Monalisa Swain, Erik K Larsen, Marcin Dyba, Oleg Chertov, Mariam Ashraf, Allison Champagne, Ken Lin, Anna Maciag, William K Gillette und 4 weitere

Journal of Biological Chemistry · 2025-07 · 301 (7) · 110331

DOI: 10.1016/j.jbc.2025.110331 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025-07. Verfasst von Patrick Alexander und 15 weiteren Autor:innen. Beteiligte Einrichtung: NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederic…. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins p21(ras). Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins p21(ras)HumansAllelesCrystallography, X-RayProtein BindingMutationBinding Sites

Stichwörter der Autor:innen

KRASX-ray crystallographycovalent inhibitorsmicroscale thermophoresissurface plasmon resonance spectroscopyswitch-II pocket

Substanzen

Proto-Oncogene Proteins p21(ras)KRAS protein, human

Autor:innen und Institutionen

  • NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland, USA.
  • BridgeBio Oncology Therapeutics, South San Francisco, California, USA.
  • Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA.
  • NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland, USA. Electronic address: stephena@nih.gov.

Förderung

  • NCI NIH HHS
  • NIGMS NIH HHS
  • NIH HHS
  • National Cancer Institute
  • Argonne National Laboratory
  • Michigan Technology Tri-Corridor
  • Office of Research Infrastructure Programs
  • U.S. Department of Health and Human Services

Zitieren

APA

Alexander, P., Chan, A. H., Rabara, D., Swain, M., Larsen, E. K., Dyba, M., Chertov, O., Ashraf, M., Champagne, A., Lin, K., Maciag, A., Gillette, W. K., Nissley, D. V., McCormick, F., Simanshu, D. K., & Stephen, A. G. (2025). Biophysical and structural analysis of KRAS switch-II pocket inhibitors reveals allele-specific binding constraints. Journal of Biological Chemistry, 301(7), 110331. https://doi.org/10.1016/j.jbc.2025.110331

Vancouver

Alexander P, Chan AH, Rabara D, Swain M, Larsen EK, Dyba M, et al. Biophysical and structural analysis of KRAS switch-II pocket inhibitors reveals allele-specific binding constraints. Journal of Biological Chemistry. 2025;301(7):110331. doi:10.1016/j.jbc.2025.110331

BibTeX
@article{Alexander2025,
  author = {Alexander, Patrick and Chan, Albert H and Rabara, Dana and Swain, Monalisa and Larsen, Erik K and Dyba, Marcin and Chertov, Oleg and Ashraf, Mariam and Champagne, Allison and Lin, Ken and Maciag, Anna and Gillette, William K and Nissley, Dwight V and McCormick, Frank and Simanshu, Dhirendra K and Stephen, Andrew G},
  title = {Biophysical and structural analysis of KRAS switch-II pocket inhibitors reveals allele-specific binding constraints},
  journal = {Journal of Biological Chemistry},
  year = {2025},
  volume = {301},
  number = {7},
  pages = {110331},
  doi = {10.1016/j.jbc.2025.110331}
}
Kostenlos starten →